Pulmonx Corporation (Nasdaq: LUNG) (the “Company” or “Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that on December 1, 2025 (the “Grant Date”), Pulmonx ...

Valve Software, creator of Steam, remains privately held, unlikely to IPO soon. Alternative investment options include shares in other public gaming firms like EA or Take-Two. Interested in gaming ...